ANAGENICS LIMITED - Announcements

0.00%

0.7¢

Market Cap $3.474M

Consumer Defensive Household & Personal Products

Anagenics Limited is an Australia-based health and beauty-tech company that operates... Anagenics Limited is an Australia-based health and beauty-tech company that operates health wellness and beauty business servicing wholesale and retail customers through omnichannel, offering premium branded products. The Company operates through its holding entity, Anagenics Limited and its main operating subsidiary company BLC Cosmetics Pty Limited (BLC) being a distributor of prestige beauty cosmetics and beauty equipment. BLC is an importer and distributor of prestige international and local skin care and wellbeing brands, namely Thalgo, Comfort Zone, Priori and other premium brands. BLC services over 1,000 spas, clinics, salons, retail stores and online in Australia, New Zealand and the Pacific Islands. The Company's brands consist of evolis and Uspa. Evolis is an anti-ageing hair care collection focused on harnessing the scientific research to give customers' thicker and healthier hair.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

AN1	Cellmid Completes $2M Placement	PRICE SENSITIVE	13/03/13	24.5KB	Share
AN1	Trading Halt	PRICE SENSITIVE	11/03/13	58.6KB	Share
AN1	Response to ASX Price Query	PRICE SENSITIVE	08/03/13	167.83KB	Share
AN1	Change of Director's Interest Notice - M Halasz		04/03/13	21.01KB	Share
AN1	Response to ASX Price Query	PRICE SENSITIVE	27/02/13	166.92KB	Share
AN1	Change of Director's Interest Notice - Martin Rogers		19/02/13	15.54KB	Share
AN1	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	15/02/13	193.97KB	Share
AN1	Cellmid Signs Midkine Diagnostic Agreement	PRICE SENSITIVE	11/02/13	28.02KB	Share
AN1	Cellmid News		29/01/13	1.09MB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/13	96.49KB	Share
AN1	Positive Data in Midkine Antibody Study in Kidney Disease	PRICE SENSITIVE	23/01/13	127.62KB	Share
AN1	Response to ASX Aware Query	PRICE SENSITIVE	22/01/13	182.07KB	Share
AN1	EU Patent Allowed for Treating Vascular Occlusive Disease	PRICE SENSITIVE	21/01/13	28KB	Share
AN1	Response to ASX Query - Diversity		15/01/13	109.9KB	Share
AN1	Appendix 3Y - M Halasz		11/01/13	17.75KB	Share
AN1	App 3Y - M Halasz		07/01/13	17.86KB	Share
AN1	Appendix 3Y M Rogers		28/12/12	172.97KB	Share
AN1	App 3Y - M Halasz		14/12/12	16.23KB	Share
AN1	Change of Director's Interest Notice - M Rogers		04/12/12	14.92KB	Share
AN1	Change of Director's Interest Notice		04/12/12	16.26KB	Share
AN1	Results of Meeting		23/11/12	23.34KB	Share
AN1	AGM Presentation by CEO		23/11/12	796.51KB	Share
AN1	Investor Presentation		20/11/12	853.77KB	Share
AN1	Response to ASX Query		13/11/12	133.27KB	Share
AN1	Change of Director's Interest Notice - M Rogers		09/11/12	37.7KB	Share
AN1	Change of Director's Interest Notice - D King		07/11/12	15.14KB	Share
AN1	Change of Director's Interest Notice - M Halasz		07/11/12	16.42KB	Share
AN1	Amended Top 20 Option Holders		29/10/12	17.58KB	Share
AN1	Dispatch of Options Entitlements Offer Holding Statements		29/10/12	87.2KB	Share
AN1	$545K Options Rights Issue Completed		24/10/12	19.66KB	Share
AN1	Annual Report to Shareholders		24/10/12	3.35MB	Share
AN1	Notice of Annual General Meeting and Proxy Form		24/10/12	103.58KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	22/10/12	94.76KB	Share
AN1	Change of Director's Interest Notice		02/10/12	14.42KB	Share
AN1	$748K R&D Tax Credit Received	PRICE SENSITIVE	02/10/12	20.36KB	Share
AN1	Initial Director's Interest Notice - M Rogers		20/09/12	9.86KB	Share
AN1	Appointment of Director		19/09/12	20.7KB	Share
AN1	Underwritten Non-Renounceable Pro-Rata Offer and Placement	PRICE SENSITIVE	14/09/12	308.55KB	Share
AN1	Evolis Hair Growth Products Exceed Distribution Targets	PRICE SENSITIVE	13/09/12	27.36KB	Share
AN1	Exclusive Distributor Appointed for evolis	PRICE SENSITIVE	04/09/12	23.43KB	Share
AN1	Final Director's Interest Notice		30/08/12	99.26KB	Share
AN1	Appendix 4E and Preliminary Final Report	PRICE SENSITIVE	30/08/12	605.71KB	Share
AN1	App 3X - Initial Director's Interests G Kaufman		28/08/12	9.45KB	Share
AN1	Appointment and Resignation of Directors		27/08/12	21.88KB	Share
AN1	Appendix 3B		21/08/12	93.45KB	Share
AN1	Appointment of Joint Company Secretary		06/08/12	19.69KB	Share
AN1	Cellmid News		30/07/12	458.85KB	Share
AN1	Response to ASX Query	PRICE SENSITIVE	27/07/12	134.8KB	Share
AN1	Appendix 3B		27/07/12	106.91KB	Share
AN1	Midkine Ischemia Patent Allowed in US	PRICE SENSITIVE	26/07/12	26.91KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	23/07/12	80.91KB	Share
AN1	Response to ASX Query		17/07/12	400.02KB	Share
AN1	Change of Director's Interest Notice - Replacement		12/07/12	28.31KB	Share
AN1	Change of Director's Interest Notice		12/07/12	13.17KB	Share
AN1	2ND EXCELLENCE IN MIDKINE RESEARCH CONFERENCE, ISTANBUL		25/06/12	60.03KB	Share
AN1	Appendix 3B		20/06/12	89.58KB	Share
AN1	Appendix 3B		07/06/12	83.4KB	Share
AN1	Evolis to be Sold in Terry White Chemist Outlets	PRICE SENSITIVE	30/05/12	24.99KB	Share
AN1	Results of Meeting		28/05/12	47.4KB	Share
AN1	Change in substantial holding		25/05/12	1.01MB	Share
AN1	Ceasing to be a substantial holder		11/05/12	2.18MB	Share
AN1	Appendix 3B		07/05/12	83.29KB	Share
AN1	Treg Antibody Patent Allowed in USA	PRICE SENSITIVE	07/05/12	234.07KB	Share
AN1	Notice of Meeting/Proxy Form		30/04/12	116.4KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	26/04/12	99.04KB	Share
AN1	Cellmid Completes $1.5M Placement	PRICE SENSITIVE	24/04/12	24.5KB	Share
AN1	Trading Halt	PRICE SENSITIVE	23/04/12	58KB	Share
AN1	Final Share Issue to La Jolla Cove - Appendix 3B		20/04/12	98.93KB	Share
AN1	Commercial website launched for Evolis		19/04/12	27.96KB	Share
AN1	USA Antibody Patent for Adhesion Allowed	PRICE SENSITIVE	18/04/12	28.04KB	Share
AN1	Appendix 3B		16/04/12	83.56KB	Share
AN1	Response to ASX Query		05/04/12	124.46KB	Share
AN1	Appendix 3B		04/04/12	83.72KB	Share
AN1	Change of Director's Interest Notice		03/04/12	13.31KB	Share
AN1	Appendix 3B		29/03/12	83.82KB	Share
AN1	Media Launch of Evolis Hair Products	PRICE SENSITIVE	29/03/12	50.12KB	Share
AN1	Appendix 3B		16/03/12	84.29KB	Share
AN1	Change of Director's Interest Notice		13/03/12	70.65KB	Share
AN1	Appendix 3B		12/03/12	84.61KB	Share
AN1	Appendix 3B		06/03/12	84.09KB	Share
AN1	Annual Report on Celera (Quest) License	PRICE SENSITIVE	05/03/12	27.94KB	Share
AN1	Appendix 4D and Half Year Accounts	PRICE SENSITIVE	28/02/12	161.26KB	Share
AN1	Appendix 3B		28/02/12	83.92KB	Share
AN1	Appendix 3B		20/02/12	86.09KB	Share
AN1	Notice of change of interests of substantial holder		20/02/12	141.49KB	Share
AN1	TGA Registration and Launch of Cellmid's Evolis Products	PRICE SENSITIVE	15/02/12	23.19KB	Share
AN1	La Jolla Cove Funding Agreement Terminated	PRICE SENSITIVE	13/02/12	27.75KB	Share
AN1	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/12	99.94KB	Share
AN1	Appendix 3B		24/01/12	98.72KB	Share
AN1	Appendix 3B		16/12/11	81.79KB	Share
AN1	Becoming a substantial holder		08/12/11	217.49KB	Share
AN1	Change of Director's Interest Notice		08/12/11	70.46KB	Share
AN1	Change of Director's Interest Notice		08/12/11	70.36KB	Share
AN1	Change of Director's Interest Notice		08/12/11	70.66KB	Share
AN1	Change of Director's Interest Notice		08/12/11	12.5KB	Share
AN1	Change of Director's Interest Notice		08/12/11	12.59KB	Share
AN1	Dispatch of Rights Issue Holdings Statements		02/12/11	25KB	Share
AN1	Completed Midkine Study for Normal Reference Range	PRICE SENSITIVE	01/12/11	26.37KB	Share
AN1	Rights Issue and Placement of Shortfall	PRICE SENSITIVE	29/11/11	19.6KB	Share
AN1	Amended Constitution		25/11/11	138.45KB	Share

AN1Cellmid Completes $2M Placement
13/03/13	PRICE SENSITIVE	24.5KB	Share
AN1Trading Halt
11/03/13	PRICE SENSITIVE	58.6KB	Share
AN1Response to ASX Price Query
08/03/13	PRICE SENSITIVE	167.83KB	Share
AN1Change of Director's Interest Notice - M Halasz
04/03/13		21.01KB	Share
AN1Response to ASX Price Query
27/02/13	PRICE SENSITIVE	166.92KB	Share
AN1Change of Director's Interest Notice - Martin Rogers
19/02/13		15.54KB	Share
AN1Appendix 4D and Half Year Accounts
15/02/13	PRICE SENSITIVE	193.97KB	Share
AN1Cellmid Signs Midkine Diagnostic Agreement
11/02/13	PRICE SENSITIVE	28.02KB	Share
AN1Cellmid News
29/01/13		1.09MB	Share
AN1Appendix 4C - quarterly
29/01/13	PRICE SENSITIVE	96.49KB	Share
AN1Positive Data in Midkine Antibody Study in Kidney Disease
23/01/13	PRICE SENSITIVE	127.62KB	Share
AN1Response to ASX Aware Query
22/01/13	PRICE SENSITIVE	182.07KB	Share
AN1EU Patent Allowed for Treating Vascular Occlusive Disease
21/01/13	PRICE SENSITIVE	28KB	Share
AN1Response to ASX Query - Diversity
15/01/13		109.9KB	Share
AN1Appendix 3Y - M Halasz
11/01/13		17.75KB	Share
AN1App 3Y - M Halasz
07/01/13		17.86KB	Share
AN1Appendix 3Y M Rogers
28/12/12		172.97KB	Share
AN1App 3Y - M Halasz
14/12/12		16.23KB	Share
AN1Change of Director's Interest Notice - M Rogers
04/12/12		14.92KB	Share
AN1Change of Director's Interest Notice
04/12/12		16.26KB	Share
AN1Results of Meeting
23/11/12		23.34KB	Share
AN1AGM Presentation by CEO
23/11/12		796.51KB	Share
AN1Investor Presentation
20/11/12		853.77KB	Share
AN1Response to ASX Query
13/11/12		133.27KB	Share
AN1Change of Director's Interest Notice - M Rogers
09/11/12		37.7KB	Share
AN1Change of Director's Interest Notice - D King
07/11/12		15.14KB	Share
AN1Change of Director's Interest Notice - M Halasz
07/11/12		16.42KB	Share
AN1Amended Top 20 Option Holders
29/10/12		17.58KB	Share
AN1Dispatch of Options Entitlements Offer Holding Statements
29/10/12		87.2KB	Share
AN1$545K Options Rights Issue Completed
24/10/12		19.66KB	Share
AN1Annual Report to Shareholders
24/10/12		3.35MB	Share
AN1Notice of Annual General Meeting and Proxy Form
24/10/12		103.58KB	Share
AN1Appendix 4C - quarterly
22/10/12	PRICE SENSITIVE	94.76KB	Share
AN1Change of Director's Interest Notice
02/10/12		14.42KB	Share
AN1$748K R&D Tax Credit Received
02/10/12	PRICE SENSITIVE	20.36KB	Share
AN1Initial Director's Interest Notice - M Rogers
20/09/12		9.86KB	Share
AN1Appointment of Director
19/09/12		20.7KB	Share
AN1Underwritten Non-Renounceable Pro-Rata Offer and Placement
14/09/12	PRICE SENSITIVE	308.55KB	Share
AN1Evolis Hair Growth Products Exceed Distribution Targets
13/09/12	PRICE SENSITIVE	27.36KB	Share
AN1Exclusive Distributor Appointed for evolis
04/09/12	PRICE SENSITIVE	23.43KB	Share
AN1Final Director's Interest Notice
30/08/12		99.26KB	Share
AN1Appendix 4E and Preliminary Final Report
30/08/12	PRICE SENSITIVE	605.71KB	Share
AN1App 3X - Initial Director's Interests G Kaufman
28/08/12		9.45KB	Share
AN1Appointment and Resignation of Directors
27/08/12		21.88KB	Share
AN1Appendix 3B
21/08/12		93.45KB	Share
AN1Appointment of Joint Company Secretary
06/08/12		19.69KB	Share
AN1Cellmid News
30/07/12		458.85KB	Share
AN1Response to ASX Query
27/07/12	PRICE SENSITIVE	134.8KB	Share
AN1Appendix 3B
27/07/12		106.91KB	Share
AN1Midkine Ischemia Patent Allowed in US
26/07/12	PRICE SENSITIVE	26.91KB	Share
AN1Appendix 4C - quarterly
23/07/12	PRICE SENSITIVE	80.91KB	Share
AN1Response to ASX Query
17/07/12		400.02KB	Share
AN1Change of Director's Interest Notice - Replacement
12/07/12		28.31KB	Share
AN1Change of Director's Interest Notice
12/07/12		13.17KB	Share
AN12ND EXCELLENCE IN MIDKINE RESEARCH CONFERENCE, ISTANBUL
25/06/12		60.03KB	Share
AN1Appendix 3B
20/06/12		89.58KB	Share
AN1Appendix 3B
07/06/12		83.4KB	Share
AN1Evolis to be Sold in Terry White Chemist Outlets
30/05/12	PRICE SENSITIVE	24.99KB	Share
AN1Results of Meeting
28/05/12		47.4KB	Share
AN1Change in substantial holding
25/05/12		1.01MB	Share
AN1Ceasing to be a substantial holder
11/05/12		2.18MB	Share
AN1Appendix 3B
07/05/12		83.29KB	Share
AN1Treg Antibody Patent Allowed in USA
07/05/12	PRICE SENSITIVE	234.07KB	Share
AN1Notice of Meeting/Proxy Form
30/04/12		116.4KB	Share
AN1Appendix 4C - quarterly
26/04/12	PRICE SENSITIVE	99.04KB	Share
AN1Cellmid Completes $1.5M Placement
24/04/12	PRICE SENSITIVE	24.5KB	Share
AN1Trading Halt
23/04/12	PRICE SENSITIVE	58KB	Share
AN1Final Share Issue to La Jolla Cove - Appendix 3B
20/04/12		98.93KB	Share
AN1Commercial website launched for Evolis
19/04/12		27.96KB	Share
AN1USA Antibody Patent for Adhesion Allowed
18/04/12	PRICE SENSITIVE	28.04KB	Share
AN1Appendix 3B
16/04/12		83.56KB	Share
AN1Response to ASX Query
05/04/12		124.46KB	Share
AN1Appendix 3B
04/04/12		83.72KB	Share
AN1Change of Director's Interest Notice
03/04/12		13.31KB	Share
AN1Appendix 3B
29/03/12		83.82KB	Share
AN1Media Launch of Evolis Hair Products
29/03/12	PRICE SENSITIVE	50.12KB	Share
AN1Appendix 3B
16/03/12		84.29KB	Share
AN1Change of Director's Interest Notice
13/03/12		70.65KB	Share
AN1Appendix 3B
12/03/12		84.61KB	Share
AN1Appendix 3B
06/03/12		84.09KB	Share
AN1Annual Report on Celera (Quest) License
05/03/12	PRICE SENSITIVE	27.94KB	Share
AN1Appendix 4D and Half Year Accounts
28/02/12	PRICE SENSITIVE	161.26KB	Share
AN1Appendix 3B
28/02/12		83.92KB	Share
AN1Appendix 3B
20/02/12		86.09KB	Share
AN1Notice of change of interests of substantial holder
20/02/12		141.49KB	Share
AN1TGA Registration and Launch of Cellmid's Evolis Products
15/02/12	PRICE SENSITIVE	23.19KB	Share
AN1La Jolla Cove Funding Agreement Terminated
13/02/12	PRICE SENSITIVE	27.75KB	Share
AN1Appendix 4C - quarterly
30/01/12	PRICE SENSITIVE	99.94KB	Share
AN1Appendix 3B
24/01/12		98.72KB	Share
AN1Appendix 3B
16/12/11		81.79KB	Share
AN1Becoming a substantial holder
08/12/11		217.49KB	Share
AN1Change of Director's Interest Notice
08/12/11		70.46KB	Share
AN1Change of Director's Interest Notice
08/12/11		70.36KB	Share
AN1Change of Director's Interest Notice
08/12/11		70.66KB	Share
AN1Change of Director's Interest Notice
08/12/11		12.5KB	Share
AN1Change of Director's Interest Notice
08/12/11		12.59KB	Share
AN1Dispatch of Rights Issue Holdings Statements
02/12/11		25KB	Share
AN1Completed Midkine Study for Normal Reference Range
01/12/11	PRICE SENSITIVE	26.37KB	Share
AN1Rights Issue and Placement of Shortfall
29/11/11	PRICE SENSITIVE	19.6KB	Share
AN1Amended Constitution
25/11/11		138.45KB	Share

REFRESH

First 4 5 6 7 8

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.7¢		Change 0.000(0.00%)		Mkt cap ! $3.474M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	1544100	0.6¢

Sellers (Offers)

Price($)	Vol.	No.
0.7¢	364754	3

View Market Depth

No.	Vol.	Price($)
2	1544100	0.006
1	750000	0.005
6	7665000	0.004
3	5450000	0.003
1	800000	0.002

Price($)	Vol.	No.
0.007	364754	3
0.008	653713	2
0.009	620000	2
0.010	500000	1
0.015	200000	1

Last trade - 16.21pm 08/08/2025 (20 minute delay)

AN1 (ASX) Chart

Day chart unavailable

ANAGENICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available